Navigation Links
Boston Scientific Announces CEO Jim Tobin to Extend Tenure
Date:6/3/2008

achieve the enormous potential of this business. The time is now right for Jim to turn his full attention and energies back to the core challenges facing the Company as a whole, especially those relating to strategy, the development of our human capital, organizational efficiency and effectiveness, and simplifying and streamlining operations. We are committed to delivering innovation, profitable growth, increased shareholder value, and a stronger Company for the future. The Board and I firmly and unanimously believe Jim is the best person to continue delivering on those commitments."

"Paul LaViolette has served this Company with passion and enthusiasm for almost 15 years, and as a friend and colleague I want to thank him for all he has done," added Nicholas.

"The Board of Directors continues to be very satisfied with Jim's effective and skillful leadership of Boston Scientific," said Warren B. Rudman, Director and Chairman of the Executive Compensation and Human Resources Committee of the Board of Directors. "All of us on the Board believe Jim remaining CEO is in the best interest of the Company, its employees, customers, patients and shareholders. We look forward to Boston Scientific realizing its full potential under Jim's leadership, and to its ongoing role as a global leader in the medical device industry."

"In the nine years I have had the honor of leading Boston Scientific, we have accomplished a great deal and made remarkable progress, but there is more to do," said Tobin. "Across the organization, our accomplishments are the result of thousands of people around the world who every day advance our mission of helping clinicians improve patients' lives through medical technology. Nowhere is the promise of medical technology greater than in CRM. For the past two years, I have had the pleasure of working directly with our talented and dedicated CRM team to rebuild that organization and make it world class again. During this time, the contribu
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
2. Boston Scientific Completes Acquisition of CryoCor
3. Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System
4. Boston Scientific Announces FDA Approval of New Heart Failure Lead
5. Boston Scientifics SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
6. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
7. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
8. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
9. Fraunhofer and Boston University Hosted Prestigious SME Tour
10. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
11. Boston Scientific Announces Results for First Quarter Ended March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 China Biologic Products, Inc. (NASDAQ: ... fully integrated plasma-based biopharmaceutical company in ... subsidiary, Shandong Taibang Biological Products Co. Ltd., has ... China Food and Drug Administration (the "CFDA") for ... disclosed in the Company,s public filings, the CFDA ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 /PRNewswire/ ... study of mazindol in children with attention deficit/hyperactivity disorder ... December 2014 . The paper, titled ... attention deficit/hyperactivity disorder" ( Konofal et al, ... eCollection 2014 ) shows that mazindol might be ...
(Date:12/22/2014)... -- GenomeDx Biosciences today announced that a new study ... test for prostate cancer, was able to predict rapid ... prostatectomy without adjuvant therapy. Although rapid metastasis in men ... genomics to identify these men who have a highly ... The study has been published online by the ...
(Date:12/19/2014)... PA (PRWEB) December 19, 2014 ... leading developer and manufacturer of needle-free injection technology, ... agreement with Immunomic Therapeutics, Inc. (“ITI”) for ITI ... device with its LAMP™ vaccine platform. , ... an exclusive Worldwide license to the Biojector®-2000 that ...
Breaking Biology Technology:China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3
... PharmAthene, Inc. (NYSE Amex: PIP ), a ... threats, today reported financial and operational results for the ... of 2009, PharmAthene recognized revenues of $5.5 million compared ... Revenues for the most recent quarter consisted primarily ...
... (OTC Bulletin Board: DORB) (DOR or the Company), a ... the first quarter of 2009. DOR,s revenues for the ... to $0.7 million for the first quarter of 2008. ... research and development amounts drawn down from DOR,s NIH ...
... Study and Orphan Drug DesignationROCKVILLE, Md., May 15 ... pharmaceutical company developing therapeutics for the treatment of cancer ... candidates at the American Society of Clinical Oncology (ASCO) ... 2, 2009 in Orlando, Florida. Presentations include both ...
Cached Biology Technology:PharmAthene Reports First Quarter 2009 Financial and Operational Results 2PharmAthene Reports First Quarter 2009 Financial and Operational Results 3PharmAthene Reports First Quarter 2009 Financial and Operational Results 4PharmAthene Reports First Quarter 2009 Financial and Operational Results 5PharmAthene Reports First Quarter 2009 Financial and Operational Results 6PharmAthene Reports First Quarter 2009 Financial and Operational Results 7DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 2DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 3DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 4DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 5EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 2EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 3EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 4EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 5
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
(Date:11/21/2014)... 20, 2014 Strict laws against distracted driving ... the North American and European automotive sector towards gesture ... recognition systems that are intuitive and able to retrieve ... industry. New analysis from Frost & ... in Europe and ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... May 31, 2012 - Traveling the western U.S. state of Nevada ... a "world of talk" about the beauty of Lake Tahoe and ... high in the Sierra Nevada Mountains. Determined to make the 11-mile ... toiling up one mountain and then another to no avail. But ...
... from three U.S. federal agencies and the White House, the ... Dr. Floyd Malveaux, expressed strong support for the government,s new ... The release of the new report came on the last ... is an outcome of the interagency Asthma Disparities Working Group, ...
... don,t need to spray weedkiller to remove the weeds between ... boiling water, steam or flaming will dispatch even the hardiest ... PhD project from the University of Copenhagen. Weeds can ... that each treatment is dosed correctly. Basically, every single ...
Cached Biology News:Wildfire and an example of its important link to the ecosystem 2Leading childhood asthma group supports federal asthma action plan to reduce disparities 2Blanch your weeds 2
... OLIGO is a multi-functional program ... oligonucleotides from a sequence file ... DNA sequencing, site-directed mutagenesis, and ... hybridization temperature and secondary structure ...
... consultation. Peptide synthesis and purification (>80% ... Conjugation to KLH. 5mg unconjugated peptide ... New Zealand white female rabbits. 70 ... production bleeds. Elisa testing Total ...
Request Info...
... O-rings, 5 barrel liners, 5 white cartridge holders, ... Helios gene gun is a convenient, hand-held device ... a range of targets in vivo. The unit ... DNA- or RNA-coated gold microcarriers from the inner ...
Biology Products: